On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Stocks To Buy Now


SenesTech Inc. (NASDAQ: SNES) Set to Revolutionize Rodent Pest Control for Everyday Consumers Following Amazon Store Launch

  • American-based SenesTech, rodent fertility control product provider, growing rapidly with its highly successful and unmatched rodent control technology, is now expanding from government and business markets to the direct consumer market with the launch of its dedicated online store on Amazon
  • This brings SenesTech and its products closer to consumers in what its management notes will help drive growth in its fertility solutions for many years to come, and carving out a significant market share in an industry that currently posts over $1 billion in sales annually
  • Amazon’s addition follows SenesTech’s recent multiple overseas distribution deals which opened it up to Europe, New Zealand, Australia, and Singapore

SenesTech (NASDAQ: SNES), a rodent fertility control product provider and the inventor of the only EPA-registered contraceptive for male and female rats, just announced the launch of its dedicated online store on Amazon. As the world’s largest online retailer, this move brings SenesTech and its products closer to consumers, marking a significant step forward in distributing its flagship Evolve(TM) soft bait (https://ibn.fm/cJrCf). 

According to Joel Fruendt, the company’s CEO, this launch positions SenesTech to revolutionize how everyday consumers safely and proactively combat rodent pests, particularly when regulations are putting more restrictions on applying commonly used poisons. It also marks a significant milestone for the company, notably since Evolve(TM) was only launched earlier in the year.

“Evolve has already garnered acclaim in the professional market since its launch at the beginning of the year,” noted Mr. Fruendt. “Now, it’s poised to revolutionize how everyday consumers can safely and proactively combat rodent pests with its availability on Amazon,” he added.

SenesTech announced multiple global distribution deals in March, opening it up to various markets, including Europe, New Zealand, Australia, and Singapore. While making the announcement, SenesTech’s management shared their optimism about these deals, citing how they would be integral in setting the company up for more success in the 2024 calendar year. The addition of the dedicated online Amazon store points to the company’s commitment to further pushing its products and ultimately carving out a significant market share in an industry that currently posts sales of over $1 billion annually.

Various studies have pointed to the overall efficiency of SenesTech’s offering. They have shown that with its contraceptives, rodent populations can be reduced by half in just six months and over 90 percent in one year. This is significant, especially given that two rats, given sufficient food, water, and harborage, will produce 15,000 offspring within a year. With the growing regulations on using poisons to control rodent populations, SenesTech is taking a more proactive approach, offering a safe, effective, and convenient alternative to traditional poison-heavy pest control.

Since its launch, Evolve’s uptake has been impressive for SenesTech. It speaks to its overall effectiveness and a glaring market gap that the company is satisfying with its superior range of products. The launch of the Amazon store now brings the products closer to customers, a move set to drive up sales and the overall adoption of the company’s products. According to Mr. Fruendt, this move is expected to drive continued growth in the company’s revolutionary fertility soft bait solutions for many years to come.

For more information, visit the company’s website at www.SenesTech.com.

NOTE TO INVESTORS: The latest news and updates relating to SNES are available in the company’s newsroom at https://ibn.fm/SNES

From Our Blog

Annovis Bio Inc. (NYSE: ANVS) Announces New Executive Team Members

July 23, 2024

Annovis Bio (NYSE: ANVS), a pioneering late-stage clinical drug platform company focusing on transformative therapies for neurodegenerative disorders such as Alzheimer’s Disease (“AD”) and Parkinson’s Disease (“PD”), is thrilled to welcome four seasoned professionals to its executive team. Maria Maccecchini, Ph.D., Founder, President, and CEO of Annovis Bio, said the company was delighted to have […]

Rotate your device 90° to view site.